CODA Biotherapeutics
Latest round
- Series A
Last raised
- Nov 2019
Total raised
- $34M
Investors
- 4
About CODA Biotherapeutics
CODA Biotherapeutics, Inc.Founded in 2014 and headquartered in South San Francisco, US, CODA Biotherapeutics, Inc. specializes in the development of biotherapeutics targeting neurological disorders.CODA Biotherapeutics is dedicated to developing cutting-edge biotherapeutic solutions aimed at treating neurological conditions such as neuropathic pain and focal epilepsy. The company aims to expand its product offerings and enhance its therapeutic pipeline, while exploring opportunities for growth in the neurological therapeutics market globally.
Who invested in CODA Biotherapeutics
4 investors across 2 rounds
See all investors in CODA Biotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CODA Biotherapeutics
Who invested in CODA Biotherapeutics?
CODA Biotherapeutics has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CODA Biotherapeutics raised?
CODA Biotherapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did CODA Biotherapeutics last raise money?
CODA Biotherapeutics's most recent round on record is a Series A, in Nov 2019.
What does CODA Biotherapeutics do?
CODA Biotherapeutics is a biotechnology company.
Where is CODA Biotherapeutics headquartered?
CODA Biotherapeutics is headquartered in South San Francisco, US.
Which VCs invest in companies like CODA Biotherapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at CODA Biotherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like CODA Biotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.